DUBLIN, July 13, 2015 /PRNewswire/ --
Dublin - Research and Markets (http://www.researchandmarkets.com/research/l97d7c/smart_pills) has announced the addition of the "Smart Pills Market by Application, Target Area & Geography - Global Forecast to 2024" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The Smart pills market in 2014 is valued at $1.56 billion. It is forecasted to reach $3.83 billion in the year 2020, growing at a CAGR of 16.16% (2014 - 2020). This will continue to reach $8.98 billion by the year 2024, growing at a CAGR of 23.7% (2020 - 2024).
The healthcare industry is witnessing a paradigm shift from traditional devices to more sophisticated and programmed ones. Growing demand for noninvasive procedures, sophisticated drug delivery techniques, and improved patient monitoring solutions are propelling the growth of this market. Companies are increasingly focusing on investing in R&D activities for the development of the smart pills technology in order to meet consumer expectations and to help in the treatment of various diseases.
The smart pills market is segmented on the basis of applications and regions. On the basis of applications, capsule endoscopy accounted for the largest share of the smart pills market in 2014. On the basis of regions, North America is expected to grow at the highest CAGR during the forecast period. The high growth of this region can be attributed to the favorable reimbursement scenario, FDA approvals for smart pills, and investment by government and other agencies.
The smart pills market has few players as two major segments of the market are under R&D phase. The companies in this market focus on growth strategies such as new product launches; agreements, partnerships, collaborations, and others (approvals and expansion) to increase their customer base.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
Companies Mentioned
- Acamp
- Bio -Images Research Ltd.
- Boston Scientific Corporation
- Capsovision, Inc.
- Cerner Corporation
- Fujifilm Holdings Corporation
- Ge Healthcare
- Given Imaging, Inc
- Karl Storz Gmbh & Co. KG
- Medimetrics S.A. DE C.V
- Olympus Corporation
- Pentax Medical Company
- Proteus Digital Health, Inc.
For more information visit http://www.researchandmarkets.com/research/l97d7c/smart_pills
Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net
